我和沈家麒医师于1982年6月13～17日出席了在西柏林举行的第六届国际动脉粥样硬化会议。会议就以下四个方面进行了学术报告和讨论。一、临床研究提出动脉粥样硬化是现代人类生活中的头号敌人。北欧、北美是动脉粥样硬化和冠心病的高发病地区。但在七十年代后期,高发病国家中,特别是美国、澳大利亚、芬兰等,冠心病死亡率有显著下降,其原因被认为是:(1)改变生活方式;(2)控制危险因素;(3)进行二级预防;(4)改进治疗措施。对心肌缺血发作的发病机理,重视冠状动脉痉挛的作用,认为14～38％心肌梗塞与冠状动脉痉挛有关。钙离子拮抗剂与硝酸酯、β阻滞剂可视为治疗心肌缺血的三种主要药物;经皮腔内冠 Dr. Shen and I attended the 6th International Atherosclerosis Conference held in West Berlin on June 13-17, 1982. The conference conducted academic reports and discussions on the following four aspects. First, clinical research suggests that atherosclerosis is the number one enemy in modern human life. Northern Europe, North America is a high incidence of atherosclerosis and coronary heart disease. However, in the late seventies, the incidence of coronary heart disease was significantly reduced in countries with high incidence, especially in the United States, Australia and Finland. The reasons for this were as follows: (1) changing lifestyle; (2) controlling risk factors; 3) secondary prevention; (4) improve treatment. The pathogenesis of myocardial ischemic attack, emphasis on the role of coronary artery spasm, that 14 to 38% of myocardial infarction and coronary artery spasm related. Calcium antagonists and nitrates, beta blockers can be seen as the treatment of myocardial ischemia of the three major drugs; percutaneous intraluminal coronary